<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d297">
    <sentence id="DDI-DrugBank.d297.s0" text="Formal drug interaction studies have not been conducted with ORENCIA.">
        <entity id="DDI-DrugBank.d297.s0.e0" charOffset="61-67"
            type="brand" text="ORENCIA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d297.s1" text="Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.">
        <entity id="DDI-DrugBank.d297.s1.e0" charOffset="50-52"
            type="drug" text="MTX"/>
        <entity id="DDI-DrugBank.d297.s1.e1" charOffset="55-60"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d297.s1.e2" charOffset="63-77"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d297.s1.e3" charOffset="84-102"
            type="group" text="TNF blocking agents"/>
        <entity id="DDI-DrugBank.d297.s1.e4" charOffset="122-130"
            type="drug" text="abatacept"/>
    </sentence>
    <sentence id="DDI-DrugBank.d297.s2" text="The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.">
        <entity id="DDI-DrugBank.d297.s2.e0" charOffset="115-121"
            type="brand" text="ORENCIA"/>
        <entity id="DDI-DrugBank.d297.s2.e1" charOffset="124-126"
            type="drug" text="MTX"/>
        <entity id="DDI-DrugBank.d297.s2.e2" charOffset="129-134"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d297.s2.e3" charOffset="137-151"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d297.s2.e4" charOffset="154-172"
            type="group" text="TNF blocking agents"/>
        <entity id="DDI-DrugBank.d297.s2.e5" charOffset="175-186"
            type="drug" text="azathioprine"/>
        <entity id="DDI-DrugBank.d297.s2.e6" charOffset="189-199"
            type="drug" text="chloroquine"/>
        <entity id="DDI-DrugBank.d297.s2.e7" charOffset="202-205"
            type="drug" text="gold"/>
        <entity id="DDI-DrugBank.d297.s2.e8" charOffset="208-225"
            type="drug" text="hydroxychloroquine"/>
        <entity id="DDI-DrugBank.d297.s2.e9" charOffset="228-238"
            type="drug" text="leflunomide"/>
        <entity id="DDI-DrugBank.d297.s2.e10" charOffset="241-253"
            type="drug" text="sulfasalazine"/>
        <entity id="DDI-DrugBank.d297.s2.e11" charOffset="260-267"
            type="drug" text="anakinra"/>
    </sentence>
    <sentence id="DDI-DrugBank.d297.s3" text="Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.">
        <entity id="DDI-DrugBank.d297.s3.e0" charOffset="31-44"
            type="group" text="TNF antagonist"/>
        <entity id="DDI-DrugBank.d297.s3.e1" charOffset="51-57"
            type="brand" text="ORENCIA"/>
        <entity id="DDI-DrugBank.d297.s3.e2" charOffset="179-193"
            type="group" text="TNF antagonists"/>
        <ddi id="DDI-DrugBank.d297.s3.d0" e1="DDI-DrugBank.d297.s3.e0"
            e2="DDI-DrugBank.d297.s3.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d297.s4" text="Concurrent therapy with ORENCIA and TNF antagonists is not recommended.">
        <entity id="DDI-DrugBank.d297.s4.e0" charOffset="24-30"
            type="brand" text="ORENCIA"/>
        <entity id="DDI-DrugBank.d297.s4.e1" charOffset="36-50"
            type="group" text="TNF antagonists"/>
        <ddi id="DDI-DrugBank.d297.s4.d0" e1="DDI-DrugBank.d297.s4.e0"
            e2="DDI-DrugBank.d297.s4.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d297.s5" text="There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.">
        <entity id="DDI-DrugBank.d297.s5.e0" charOffset="70-76"
            type="brand" text="ORENCIA"/>
        <entity id="DDI-DrugBank.d297.s5.e1" charOffset="109-116"
            type="drug" text="anakinra"/>
        <ddi id="DDI-DrugBank.d297.s5.d0" e1="DDI-DrugBank.d297.s5.e0"
            e2="DDI-DrugBank.d297.s5.e1" type="advise"/>
    </sentence>
</document>
